Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Med Chem ; 43(11): 2135-48, 2000 Jun 01.
Article in English | MEDLINE | ID: mdl-10841792

ABSTRACT

Molecular features of ligand binding to MHC class II HLA-DR molecules have been elucidated through a combination of peptide structure-activity studies and structure-based drug design, resulting in analogues with nanomolar affinity in binding assays. Stabilization of lead compounds against cathepsin B cleavage by N-methylation of noncritical backbone NH groups or by dipeptide mimetic substitutions has generated analogues that compete effectively against protein antigens in cellular assays, resulting in inhibition of T-cell proliferation. Crystal structures of four ternary complexes of different peptide mimetics with the rheumatoid arthritis-linked MHC DRB10401 and the bacterial superantigen SEB have been obtained. Peptide-sugar hybrids have also been identified using a structure-based design approach in which the sugar residue replaces a dipeptide. These studies illustrate the complementary roles played by phage display library methods, peptide analogue SAR, peptide mimetics substitutions, and structure-based drug design in the discovery of inhibitors of antigen presentation by MHC class II HLA-DR molecules.


Subject(s)
Antigen Presentation , Dipeptides/pharmacology , HLA-DR Antigens/chemistry , Molecular Mimicry , Binding, Competitive , Carbohydrates/chemistry , Cathepsin B/metabolism , Cell Division/drug effects , Crystallography, X-Ray , Dipeptides/chemical synthesis , Dipeptides/chemistry , Humans , Methylation , Models, Molecular , Peptide Biosynthesis , Protein Conformation , Structure-Activity Relationship , T-Lymphocytes/cytology , T-Lymphocytes/drug effects
2.
J Med Chem ; 37(9): 1262-8, 1994 Apr 29.
Article in English | MEDLINE | ID: mdl-8176704

ABSTRACT

A novel entry to tropane analogs of cocaine was developed on the basis of the reaction of rhodium-stabilized vinylcarbenoids with pyrroles. These analogs were tested in binding to dopamine and serotonin (5-HT) transporters in membranes from rat striatum and frontal cortex. In all the analogs, the aryl group at the 3-position was directly bound to the tropane ring (as in WIN-35,428), and methyl or ethyl ketone moieties were present at the 2-position instead of the typical ester group. The series of analogs containing a 2-naphthyl group at the 3-position were most potent, with Ki values < 1 nM in binding to both dopamine and 5-HT transporters. Although the unsubstituted 2-naphthyl analog was nonselective at dopamine and 5-HT transport sites, other compounds were selective for either site. In general, compounds with relatively small substituents on the aromatic moiety (such as p-methyl or p-fluoro) were relatively selective for the dopamine transporters, while a p-isopropylphenyl derivative was selective for the 5-HT transport sites. This latter compound represents the first N-methyltropane derivative specific for 5-HT transporters. Resolution of two of the most significant analogs was achieved by HPLC on a chiral stationary phase; the active enantiomer of a 2-naphthyl analog exhibited Ki values of < 0.1 nM at both dopamine and 5-HT transporter sites.


Subject(s)
Carrier Proteins/metabolism , Cocaine/analogs & derivatives , Corpus Striatum/metabolism , Frontal Lobe/metabolism , Membrane Glycoproteins/metabolism , Membrane Transport Proteins , Nerve Tissue Proteins , Animals , Binding Sites , Binding, Competitive , Cocaine/metabolism , Dopamine Plasma Membrane Transport Proteins , Male , Molecular Structure , Pyrroles/chemistry , Rats , Rats, Sprague-Dawley , Rhodium , Serotonin Plasma Membrane Transport Proteins , Structure-Activity Relationship , Tritium
3.
Biochem Pharmacol ; 43(3): 419-23, 1992 Feb 04.
Article in English | MEDLINE | ID: mdl-1540199

ABSTRACT

The natural toxin anatoxin-a (AnTx) is a potent nicotinic agonist that is valuable for the study of nicotinic receptors. We have synthesized 2-(propan-1-oxo-1-yl)-9-azabicyclo[4.2.1]non-2-ene, the homologue of AnTx in which the side-chain is extended by one methylene unit from a methyl to an ethyl ketone. This chemistry would allow the generation of a tritiated product and the homologue, designated homoanatoxin (HomoAnTx), has been characterized here with that aim in mind. In competition binding assays at neuronal nicotinic ligand binding sites characterized by [3H]nicotine and [125I]-alpha bungarotoxin, HomoAnTx retained the same potency as the parent molecule, with Ki values of 7.5 nM and 1.1 microM, respectively. In contrast, it showed little inhibition of muscarinic binding defined by [3H]-quinuclidinyl benzilate. HomoAnTx is a potent nicotinic agonist in frog muscle contracture assays, having four times the potency of carbamylcholine and one tenth of the activity of AnTx itself. The N-methylated version of HomoAnTx was more than two orders of magnitude weaker in both functional and binding assays. The successful synthesis of HomoAnTx with retention of high nicotinic potency offers a route for the generation of novel, potent radiolabelled nicotinic ligands.


Subject(s)
Aza Compounds/chemical synthesis , Bacterial Toxins/chemistry , Bridged Bicyclo Compounds, Heterocyclic , Bridged Bicyclo Compounds/chemical synthesis , Marine Toxins/chemistry , Animals , Aza Compounds/pharmacology , Binding Sites/drug effects , Binding, Competitive , Bridged Bicyclo Compounds/pharmacology , Cyanobacteria Toxins , Isotope Labeling , Microcystins , Muscle Contraction/drug effects , Receptors, Nicotinic/drug effects , Tropanes
SELECTION OF CITATIONS
SEARCH DETAIL
...